CIBC Bank USA’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,836
Closed -$376K 281
2017
Q3
$376K Buy
1,836
+167
+10% +$38.8K 0.05% 180
2017
Q2
$406K Buy
1,669
+443
+36% +$104K 0.05% 172
2017
Q1
$293K Sell
1,226
-343
-22% -$79.9K 0.04% 203
2016
Q4
$330K Sell
1,569
-330
-17% -$68.4K 0.05% 184
2016
Q3
$438K Sell
1,899
-1,386
-42% -$339K 0.07% 165
2016
Q2
$759K Buy
3,285
+1,385
+73% +$319K 0.12% 109
2016
Q1
$510K Buy
1,900
+91
+5% +$26K 0.09% 133
2015
Q4
$565K Sell
1,809
-2
-0.1% -$595 0.1% 131
2015
Q3
$492K Buy
1,811
+292
+19% +$89.7K 0.09% 142
2015
Q2
$461K Buy
1,519
+195
+15% +$58.2K 0.08% 168
2015
Q1
$394K Buy
+1,324
New +$377K 0.07% 177

Other funds holding AGN

CIBC Bank USA's AGN Position: Q4 2017 in Review

CIBC Bank USA sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,836 shares — an estimated $376K sold.

CIBC Bank USA first reported a position in AGN in Q1 2015 and held it in 11 quarters. The position peaked at $759K in Q2 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • CIBC Bank USA reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • CIBC Bank USA sold 1,836 Allergan plc shares in Q4 2017, an estimated $376K.
  • CIBC Bank USA first reported a position in Allergan plc in Q1 2015 and held it in 11 quarters.
  • CIBC Bank USA's Allergan plc position peaked at $759K in Q2 2016.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on CIBC Bank USA's 13F filing for Q4 2017, filed 19 Jan 2018.